Alaunos Therapeutics
(NASDAQ) TCRT
Alaunos Therapeutics Financials at a Glance
Market Cap
$6.94M
Revenue (TTM)
$5.00K
Net Income (TTM)
$4.18M
EPS (TTM)
$-2.25
P/E Ratio
-1.30
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$2.80
Volume
11,273.551
Open
$2.89
Price
$2.80
Volume
11,273.551
Open
$2.89
Previous Close
$2.92
Daily Range
$2.77 - $2.92
52-Week Range
$1.67 - $6.20
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$2.80
Volume
11,273.551
Open
$2.89
Previous Close
$2.92
Daily Range
$2.77 - $2.92
52-Week Range
$1.67 - $6.20
TCRT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alaunos Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Holger Weis, CPA
Website
www.alaunos.comHeadquarters
Houston, TX 77054, US
TCRT Financials
Key Financial Metrics (TTM)
Gross Margin
-36%
Operating Margin
-845%
Net Income Margin
-835%
Return on Equity
-198%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-76.92%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.94M
Shares Outstanding
2.38M
Volume
11.27K
Short Interest
0.00%
Avg. Volume
16.13K
Financials (TTM)
Gross Profit
$5.00K
Operating Income
$4.22M
EBITDA
$4.22M
Operating Cash Flow
$2.87M
Capital Expenditure
$98.00K
Free Cash Flow
$2.97M
Cash & ST Invst.
$1.39M
Total Debt
$0.00
Alaunos Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.00K
-25.0%
Gross Profit
$3.00K
-25.0%
Gross Margin
100.00%
N/A
Market Cap
$6.94M
N/A
Market Cap/Employee
$6.94M
N/A
Employees
1
N/A
Net Income
$893.00K
-20.4%
EBITDA
$900.00K
-21.3%
Quarterly Fundamentals
Net Cash
$1.39M
+26.9%
Accounts Receivable
$3.00K
-40.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.41%
N/A
Return on Invested Capital
-1.96%
N/A
Free Cash Flow
$553.00K
+6.6%
Operating Cash Flow
$552.00K
+6.8%